PG241108C177500
- 0.03
- +0.02+200.00%
Procter & Gamble Newsroom
Dow Rallies 281 Points On Gains For Procter & Gamble, Travelers Shares
FDA recommends stopping the use of common decongestants in cold medicines, glaxosmithkline (GSK.US) and other companies may be affected.
The Food and Drug Administration (FDA) announced on Thursday that it has proposed to remove the oral phenylephrine commonly used in cold and cough syrups from the active ingredients of over-the-counter nasal decongestants and deemed it ineffective.
FDA Proposes Removing Oral Decongestant Phenylephrine From OTC Meds
The Procter & Gamble Company (PG): Steady Sales Growth and Market Leadership
Market Chatter: Unilever, Procter & Gamble Supply Chains Face Risks From Potential US Tariffs on Mexico
Express News | The USA FDA proposed to stop using the common decongestants in cold medicines.
P&G to Webcast Presentation From P&G Investor Day, November 21
Shareholders Would Enjoy A Repeat Of Procter & Gamble's (NYSE:PG) Recent Growth In Returns
Express News | Exclusive-P&G, Unilever Among Consumer Companies Exposed to Potential Trump Tariffs on Mexico -Import Data Shows
Does Procter & Gamble (NYSE:PG) Have A Healthy Balance Sheet?
Performance Comparison: Procter & Gamble And Competitors In Household Products Industry
Home Depot, 3M Share Losses Contribute To Dow's Nearly 175-Point Drop
Gillette and Movember: A Mustache-Raising Partnership for Men's Health
Why The Procter & Gamble Company (PG) Is the Best Cleaning Materials Stock to Invest in Now
Are Investors Undervaluing The Procter & Gamble Company (NYSE:PG) By 27%?
Procter & Gamble Company (The) (PG) Is Attracting Investor Attention: Here Is What You Should Know
Redburn Adjusts Price Target on Procter & Gamble to $182 From $180, Maintains Buy Rating
Unpacking the Latest Options Trading Trends in Procter & Gamble
Procter & Gamble Insider Sold Shares Worth $408,170, According to a Recent SEC Filing
Truist Financial Maintains Procter & Gamble(PG.US) With Buy Rating, Announces Target Price $180